
Photo: drdavidherediav.com
Jul 23, 2025, 07:22
David Heredia: New CA: A Cancer Journal for Clinicians Review on EGFR
David Heredia, Head of the Oncology Department at Punta Médica, shared an article on X:
“New CA: A Cancer Journal for Clinicians review on EGFR-mutant NSCLC: All major trials.
Key poor prognostic clinical/molecular factors to guide care
A Must-read review.”
Title: Personalized care for patients with EGFR-mutant non-small cell lung cancer: Navigating early to advanced disease management
Authors: Maxime Borgeaud, Timothée Olivier, Jair Bar, Stephanie Saw, Kaushal Parikh, Giuseppe Banna, Claudio De Vito, Jill Feldman, Xiuning Le, Alfredo Addeo
Read the Full Article on CA: A Cancer Journal for Clinicians.
More posts featuring David Heredia.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 23, 2025, 07:22
Jul 23, 2025, 07:19
Jul 23, 2025, 06:35
Jul 23, 2025, 06:32
Jul 23, 2025, 06:01